Market Summary | Major Indices | Market Movers | Market Sectors | Mutual Funds | A-Z Stock Listings
ETF Screener | World Markets | Currencies | CEO Wealthmeter | Oil / Energy | Metals
Treasury Rates | Calculators | My Watchlist | My Portfolio
         Symbol Lookup
BIOSCRIP Add to My Watchlist (NSDQ: BIOS) 
Detailed Quote
News
Chart
SEC Filings
Profile
Historical
Options
     BioScrip 6.59 -0.03 (-0.45%) 287,545
100 Clearbrook Road
Elmsford, NY 10523 US
(914) 460-1600
(914) 460-1660 fax
www.bioscrip.com
CEO Richard H. Friedman
Auditor Ernst & Young, LLP
Exchange Traded NQ
ISIN Number US09069N1081
CIK Number 1014739
NAICS Code 621999
Business Summary
A specialty pharmaceutical healthcare organization that partners with patients, physicians, healthcare payors and pharmaceutical manufacturers to provide access to medications and management solutions.
Number of Employees 825
Share Fundamentals
Market Cap 259.10M
Shares Outstanding 39.32M
Float 36.95M
Short Interest 1.96M
Financial Strength
Revenue (TTM) $1,354,547,000
Earnings (TTM) -$63,175,000
Quick Ratio 1.2:1
Current Ratio 1.6:1
Total Debt/Equity 0.35:1
Profitability
Gross Margin 11.7%
EBITDA Margin 1.9%
Profit Margin -5.6%
Powered By: FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes.
All other data is delayed at least 20 minutes.
By accessing this page, you agree to the following terms and conditions.
Stock News provided by MarketMinute.com
Stock Analysis provided by SocialPicks Conference calls info supplied by OpenCompany
Fundamental data supplied by Mergent, Inc.
Stock quote data supplied by Telekurs